European Society of Toxicology in Vitro ESTIV

What European Society of Toxicology in Vitro ESTIV does

European Society of Toxicology in Vitro (ESTIV), founded in 1994 and registered in Oss, the Netherlands, is a non-profit professional scientific society advancing in vitro toxicology and New Approach Methodologies (NAMs) for chemical safety assessment. The society is governed by an executive board of 6–12 officers led by President Dr. Helena Kandarova and Vice President Dr. Clive Roper, with a small operational staff of approximately five, and works in close proximity to EU regulatory bodies including EURL ECVAM, ECHA, OECD, and EFSA.

ESTIV's core products and services comprise (1) biennial international congresses (Barcelona-Sitges 2022, Prague 2024, Maastricht 2026 — the 23rd edition); (2) a 6-day Applied In Vitro Toxicology Training Course, recognized by EUROTOX for European Registered Toxicologist (ERT) accreditation and hosted annually at venues including Luxembourg Institute of Science and Technology and Bratislava since 2015; (3) a free monthly webinar series jointly organized with the American Society for Cellular and Computational Toxicology (ASCCT), archived for members; (4) a publications program including four books in the Springer Methods in Molecular Biology series and recurring special issues of the Toxicology in Vitro journal; (5) an Early Career Network (ECN) with mentorship programming; and (6) awards and bursaries, including the inaugural Liebsch & Spielmann Award for Contributions to the Validation of Alternative Methods (2026).

ESTIV funds its operations through individual and corporate membership fees (with corporate membership categories and minimum amounts set by the general assembly), biennial congress registration fees, training course tuition, publication royalties, and participation in EU-funded research projects such as the in3 Innovative Training Network (Marie Sklodowska-Curie) and ONTOX. Its primary customer segments are academic toxicology researchers, industry toxicologists in pharmaceutical, chemical, and cosmetics sectors, regulatory professionals, and early-career scientists, with 15+ corporate members and six formal MoU partnerships spanning Europe, North America, and Asia.

Name

European Society of Toxicology in Vitro ESTIV

Legal name

European Society of Toxicology In Vitro

Website

https://estiv.org

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

1–10 employees

Short description

ESTIV is a Netherlands-based non-profit scientific society, founded in 1994, that advances in vitro toxicology and New Approach Methodologies (NAMs) for chemical safety assessment through biennial international congresses, an ERT-accredited training course, monthly webinars, publications, and EU research projects, serving academic, industry, and regulatory stakeholders.

Ownership category

akta.pro rank

Headquarters

HQ city

Oss

HQ country

Netherlands

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Fees: Annual membership fees from individual and corporate members, with different contribution levels as set by the general assembly.
2. Corporate Membership: Legal entities (corporate sponsors) pay annual fees to the society with different categories and minimum amounts set by the general assembly.
3. Congress Registration Fees: Revenue from ESTIV Congress registrations including early bird, regular, and student rates for the international congresses.
4. Training Course Fees: Fees for the 6-day Applied In Vitro Toxicology Training Course held annually, eligible for ERT accreditation.
5. Publication Royalties: Royalties from published books including Validation of Alternative Methods for Toxicity Testing, In Vitro Toxicology Systems, Protocols in In Vitro Hepatocyte Research, and Human Neural Stem Cells.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

ESTIV is a non-profit scientific society that provides a platform for the in vitro toxicology community through biennial international congresses, an applied training course eligible for ERT accreditation, monthly joint webinars with ASCCT, scientific publications, awards and bursaries, and early-career networking. The society serves academic researchers, industry toxicologists, regulatory bodies, and corporate sponsors engaged in New Approach Methodologies (NAMs) and non-animal testing for chemical safety assessment.

Product overview

ESTIV is a professional scientific society, not a product company. It provides a platform for in vitro toxicology research and education through congresses, training courses, webinars, publications, awards, and early career support. The society organizes major international congresses (ESTIV 2026, 2024, 2022), runs an Applied Training Course recognized for ERT accreditation, hosts joint webinars with ASCCT, publishes scientific books, and offers awards and bursaries. ESTIV also participates in EU research projects like in3 and ONTOX.

Differentiator

Problem solved

Functional benefit

Products and services

• ESTIV International Congress Biennial international congress bringing together researchers, industry toxicologists, and regulators in in vitro toxicology and New Approach Methodologies (NAMs). The 23rd edition is scheduled for June 29–July 2, 2026 in Maastricht, following ESTIV 2024 in Prague and ESTIV 2022 in Barcelona-Sitges. Registration is open with early-bird, regular, and student rate tiers.
• ESTIV Applied In Vitro Toxicology Training Course A 6-day intensive residential training course in applied in vitro toxicology recognized by EUROTOX as eligible for European Registered Toxicologist (ERT) accreditation. Hosted at European research venues including the Luxembourg Institute of Science and Technology and Bratislava, with bursaries available for participants. The course has run annually since 2015.
• ESTIV-ASCCT Joint Webinar Series Free monthly joint webinar series with the American Society for Cellular and Computational Toxicology (ASCCT) covering topics in in vitro and in silico toxicology. Webinars are recorded and archived for ESTIV members.
• ESTIV Scientific Publications Program ESTIV-authored and ESTIV-supported books on in vitro toxicology published through the Springer Nature Methods in Molecular Biology series, including titles such as Validation of Alternative Methods for Toxicity Testing, In Vitro Toxicology Systems, Protocols in In Vitro Hepatocyte Research, and Human Neural Stem Cells. The society also supports Special Issues in the Toxicology in Vitro journal linked to its biennial congresses.

Quantifiable outcome

• 6-day ESTIV Applied Training Course eligible for ERT accreditation
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• American Society for Cellular and Computational Toxicology (ASCCT)coreStrategic or Co-development PartnerESTIV has a Memorandum of Understanding with ASCCT and jointly organizes monthly webinars, award series, and supports mutual congress participation. ASCCT has 10th Annual Meeting featured on ESTIV events.
• Japanese Society for Alternatives to Animal Experiments (JSAAE)coreStrategic or Co-development PartnerMoU partnership with JSAAE for joint activities in alternatives to animal testing. JSAAE lunch sessions held at ESTIV congresses.
• European Society for Animal Cell Technology (ESACT)minorStrategic or Co-development PartnerMoU partnership with ESACT for collaboration on animal cell technology and alternatives.
• Czech Society of Toxicology (CZT)minorStrategic or Co-development PartnerMoU partnership with CZT for toxicology collaboration in Central Europe.
• Ukrainian Scientific CenterminorStrategic or Co-development PartnerMoU partnership with Ukrainian center for toxicology research cooperation.
• European Society for Alternatives to Animal Testing (EUSAAT)coreStrategic or Co-development PartnerMoU partnership with EUSAAT. ESTIV and EUSAAT signed agreement for collaboration. EUSAAT congress 2024 held in Linz, Austria with joint promotion.
• ONTOX ProjectcoreStrategic or Co-development PartnerESTIV has signed MoU with ONTOX project. ONTOX provides webinars and training on NAMs and adverse outcome pathways.
• in3 Project (Innovative Training Network)coreStrategic or Co-development PartnerESTIV is involved in the in3 project funded by EU Marie Sklodowska-Curie Action ITN. Project focuses on in vitro and in silico tools for human chemical and nanomaterial safety assessment.
• EURL ECVAMcoreStrategic or Co-development PartnerESTIV maintains close relationship with EURL ECVAM (European Union Reference Laboratory for Alternatives to Animal Testing). ESTIV publishes JRC/ECVAM reports and supports validation activities.
• OECDcoreStrategic or Co-development PartnerESTIV collaborates with OECD on test guideline development and validation of alternative methods. ESTIV congresses feature OECD-related sessions.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Regional players

• NICEATM (NTP Interagency Center for the Evaluation of Alternative Toxicological Methods): US federal programme coordinating evaluation and validation of alternative toxicological methods. Functional counterpart to EURL ECVAM in the US; comparable public-interest role in NAMs validation.
• AFSSAPS / EURL ECVAM (European Commission Joint Research Centre): EU reference laboratory for alternatives to animal testing. ESTIV works closely with EURL ECVAM but EURL ECVAM is a regulator/funder rather than a peer society; included for context on the NAMs stakeholder ecosystem.

Direct peers

• European Society for Alternatives to Animal Testing (EUSAAT): European society promoting alternative methods to animal testing. Operates the annual Linz congress; MoU partner of ESTIV with overlapping scope in NAMs and 3Rs.
• Japanese Society for Alternatives to Animal Experiments (JSAAE): Japanese society dedicated to alternatives to animal testing. MoU partner of ESTIV with joint lunch sessions at congresses; comparable Asia-Pacific counterpart in the NAMs community.
• Institute for In Vitro Sciences (IIVS): US-based non-profit laboratory and training organization promoting in vitro approaches. Comparable mission (training, validation, regulatory engagement) but operates a working lab rather than a society model.
• American Society for Cellular and Computational Toxicology (ASCCT): US-based scientific society focused on in vitro and computational toxicology. ESTIV's closest international peer — they jointly run monthly webinars and exchange awards under an MoU.
• Center for Alternatives to Animal Testing (CAAT), Johns Hopkins University: Johns Hopkins-based center advancing alternatives to animal testing in research and education. Comparable in convening role within the NAMs field, with academic backing and US regulatory influence.

Broad incumbents

• Society of Toxicology (SOT): Largest professional toxicology society globally. Broader scope than ESTIV but with dedicated alternatives-focused special interest groups that overlap with ESTIV's audience and sponsor pool.
• EUROTOX (Federation of European Toxicologists & European Societies of Toxicology): Federation of European toxicology societies and the body that grants the European Registered Toxicologist (ERT) credential for which ESTIV's training course is eligible. Larger and broader scope, but overlapping audience.

Emerging players

• European Society for Animal Cell Technology (ESACT): European society focused on animal cell technology with overlap into in vitro methods. MoU partner of ESTIV; less toxicology-specific but adjacent scientific community.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/european-society-of-toxicology-in-vitro-estiv

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Society of Toxicology in Vitro ESTIV